Open Access Peer Reviewed ISSN: 2476-0277

Aperito Journal of Recent Trends in Genomics and Proteomics

International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.

Submit Manuscript

About the Journal

Aperito Journal of Recent Trends in Genomics and Proteomics is an international, peer-reviewed, open-access journal publishing high-quality research, reviews, case studies, short communications, and scholarly perspectives.

The journal welcomes contributions in Genome science, proteomics, sequencing technologies, biomarkers, computational omics, and translational biology. It supports authors, editors, and reviewers through transparent editorial handling, ethical peer review, and timely publication workflows.

Scope of the Journal

  • Original research and evidence-based reviews
  • Clinical, laboratory, engineering, or field studies relevant to the discipline
  • Method development, technology applications, and interdisciplinary work
  • Case reports, short communications, perspectives, and editorial commentary
  • Open-access dissemination for researchers, practitioners, and institutions

Open Access Statement

All accepted articles are published for broad visibility and responsible reuse with attribution. Authors retain appropriate scholarly credit while readers receive immediate access to published work.


Recent Articles

View All
Original Research
Developing Biomarkers for PI3K-targeted Cancer Therapies

Jing Zhang 01 Nov 2016

Original Research
Recent Advances in LINE-1 Retrotransposon Biology in the Brain

Chi Zhang 19 Mar 2015

PDF
Abstract:

It is now widely recognized that retrotransposons such as Long Interspersed Element-1 (LINE1 or L1s) have played an instrumental role in shaping the structure and function of our genomes. L1s contribute to ~17% of total human genome, and there is increasing evidence of its active role in neuronal development. L1s retro transposition was proposed as a potential mechanism of generating neuronal genome diversity, and multiple groups have attempted to characterize L1s retrotransposition events and their impacts on brain function and physiology. L1s are also linked to cognitive and psychiatric diseases such as Rett syndrome and schizophrenia. Here, I discuss the recent progress in characterizing the L1s retrotransposition in neuronal development, and how the knowledge has contributed to our understanding of brain function and diseases. 

 

Original Research
Proteomics: Method for Studying Vascular Connection Proteins between Scions Grafted on Rootstock

Byoung Ryong Jeong1, 2, 3* and Sowbiya Muneer4 21 Oct 2014

Original Research
An Alternative of Phosphopeptide Identification using Inclusion List-Driven Targeted Liquid-Tandem Mass Spectrometry for Label-Free Quantitative Tyrosine Phosphoproteomics: Application of Src Inhibitor-Related Signaling Pathway Analyses in Lung Cancer

Ming-Chuan Wang1,2, Eric S.L. Hsiaoa,2, Yu-Chang Tyan3,4,5, Tzu-Hsien Yang6, Juo-Ling Sun2, Hsin-Yi Wu7, Wen Chang Tseng8, Yu-Ju Chen7, Yeou-Guang Tsay8, Sergei Moshkovskii 9, Yu-Chen Chang 2, Wei-Sheng Wu6 and Pao Chi Liao*1,2 06 Oct 2014

PDF
Abstract:

Tyrosine phosphorylation plays a critical role in cell biological functions, particularly in signal transduction. Mass spectrometry (MS)-based proteomic analysis of tyrosine-phosphorylated (pTyr) proteins  remains challenging due to their relatively low abundance. The methods of phosphopeptide enrichment are developed prosperously such as IMmuno Affinity hromatography (IMAC) and Metal Oxide Affinity Chromatography (MOAC). However, the complexity of experimental design for sample separation induces the unnecessary variations, particularly in label-free study designs. Here, we report an alternative approach, Inclusion List-driven Targeted LC tandem MS (ILT LC-tandem MS), and demonstrate the results  obtained  are comparable with that of phosphopeptide enrichment for increasing the sequencing possibility of low abundant pTyr peptides. In the present study, ILT LC-M/MS was applied for comparative label free quantitative tyrosine phosphor proteomic analysis between Src inhibitor (dasatinib)-treated and untreated CL1-5 lung cancer cells. A total of 512 distinct pTyr sites corresponding to 491 peptides had been identified. According to evaluation using Mascot Delta score (MD score), that 88.8% of the pTyr sites were considered confidently determined. In addition, the possibility of identifying multi phosphorylated peptides by ILT LC- tandem MS was 11% higher than that by TiO2-based phosphopeptide enrichment previously reported. After the comparative label-free quantitative analysis, among the 491 pTyr peptides identified 103 showed the significant level alteration of tyrosine phosphorylation between dasatinib-treated and untreated cells, and among which 53 altered pTyr peptides were matched to contain Src kinase substrate motifs. Using pathway analysis of the corresponding proteins, the results illustrated that 17 proteins were regulated by E2F transcription factor 1, which is known to be related to cell cycle regulation, and therefore provided a credible basis for further investigations. Our data demonstrate that the utility of an alternative approach, ILT LC--tandem MS, increases the sequencing possibility of low abundant pTyr peptides and reduces the induced variations in conventional TiO2 enrichment label-free quantitative analysis.